SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Bogdanoff who wrote (175)4/17/1997 3:55:00 PM
From: James Yegerlehner   of 1972
 
David-

I agree. Point well taken. I was mistaken about the anecdote being in the annual report. It was in an article in the WSJ. I clipped the article and kept it in the pages of my 93 annual report. I don't have the date on the clipping ('94 I think), but the title is "Foreign Gene Is Implanted in Tumors In Advance for Gene-Therapy Medicine" by Michael Waldholz, staff reporter. The last paragraph reads:
======
The scientists found that in one patient, the gene injected into a tumor cell generated an attack that wiped out the tumor and also stirred an attack on tumors elsewhere in the patient's body. Dr. Nabel said the key to the technique will be its ability to stimulate a bodywide immune-system attack, since it will be impractical to directly inject the gene material into every cancer cell.
======

Regards,

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News